Your search returned 337 results.

Sort
Results
The European Union and the drug phenomenon : frequently asked questions by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lisbon EMCDDA 2010
Availability: Items available for reference: VAD: Not for loan (1).
Cannabis : health and social responses [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lisbon EMCDDA 2021
Availability: Items available for reference: VAD: Not for loan (1).
New psychoactive substances: health and social responses [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lisbon EMCDDA 2021
Availability: Items available for reference: VAD: Not for loan (1).
Opioids: health and social responses [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lisbon EMCDDA 2021
Availability: Items available for reference: VAD: Not for loan (1).
Implementing quality standards for drug services and systems : a six-step guide to support quality assurance [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lisbon EMCDDA 2021
Availability: Items available for reference: VAD: Not for loan (1).
European Monitoring Centre for Drugs and Drug Addiction : annual report : 2005 : selected issues [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lisboa EMCDDA 2005
Availability: Items available for reference: VAD: Not for loan (1).
Drugs and vulnerable groups of young people [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Series: Selected issuesLanguage: Engels
Publication details: Lisbon EMCDDA 2008
Availability: Items available for reference: VAD: Not for loan (1).
Synthetic cannabinoids in Europe : a review [PDF] Series: Technical reportLanguage: Engels
Publication details: Lisbon European Monitoring Centre for Drugs and Drug Addiction [EMCDDA] 2021
Availability: Items available for reference: VAD: Not for loan (1).
Annual report on the state of the drugs problem in the European Union : 1998 : summary and highlights [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lisboa EMCDDA 1998
Availability: Items available for loan: VAD (1)Call number: BOX161.
New benzodiazepines in Europe : a review [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lisbon EMCDDA 2021
Availability: Items available for reference: VAD: Not for loan (1).
Drug-related deaths and mortality in Europe: update from the EMCDDA expert network [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Series: Technical reportLanguage: Engels
Publication details: Lisbon EMCDDA 2021
Availability: Items available for reference: VAD: Not for loan (1).
Risk assessment report on a new psychoactive substance: methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3-dime- thylbutanoate (4F-MDMB-BICA) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended) [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lisbon EMCDDA 2021
Availability: Items available for reference: VAD: Not for loan (1).
Risk assessment report on a new psychoactive substance: methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3-dimethylbutanoate (4F-MDMB-BICA) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended) [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lisbon EMCDDA 2020
Availability: Items available for reference: VAD: Not for loan (1).
EMCDDA operating guidelines for the risk assessment of new psychoactive substances [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lisbon EMCDDA 2020
Availability: Items available for reference: VAD: Not for loan (1).
EMCDDA technical report on the new psychoactive substance methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3-dimethylbutanoate (4F-MDMB-BICA) [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lisbon EMCDDA 2020
Availability: Items available for reference: VAD: Not for loan (1).
EMCDDA technical report on the new psychoactive substance methyl 3,3-dimethyl-2-{[1-(pent-4-en-1-yl)-1H-indazole-3-carbonyl]amino}butanoate (MDMB-4en-PINACA) [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lisbon EMCDDA 2020
Availability: Items available for reference: VAD: Not for loan (1).
Isotonitazene Report on the risk assessment of N,N-diethyl-2- [[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1Hbenzimidazole-1-ethanamine (isotonitazene) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended) [PDF] by
  • European Monitoring Center for Drugs and Drug Addiction [EMCDDA]
Series: Risk assessments ; 31Language: Engels
Publication details: Lisbon EMCDDA 2020
Availability: Items available for reference: VAD: Not for loan (1).
ESPAD report 2019 : results from the European School Survey Project on Alcohol and Other Drugs [PDF] by
  • ESPAD Group
Language: Engels
Publication details: Lisbon EMCDDA 2020
Availability: Items available for reference: VAD: Not for loan (1).
Impact of COVID-19 on patterns of drug use and drugrelated harms in Europe [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lisbon EMCDDA 2020
Availability: Items available for reference: VAD: Not for loan (1).
Impact of COVID-19 on drug services and help-seeking in Europe : EMCDDA trendspotter briefing [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lisbon EMCDDA 2020
Availability: Items available for reference: VAD: Not for loan (1).
Pages